白内障超声乳化联合IOL植入术治疗晶状体溶解性青光眼

Therapeutic effect of phacoemulsification and intraocular lens implantation for phacolytic glaucoma

目的: 探讨白内障超声乳化联合人工晶状体植入术治疗晶状体溶解性青光眼的疗效。方法: 对晶状体溶解性青光眼行白内障超声乳化联合人工晶状体植入术,观察术中术后手术并发症,对比入院时及术后的视力及眼压。结果: 手术并发症轻且易于控制;17例术前眼压41.7～62.4mmHg,视力光感,术后眼压平稳于10.7～18.2mmHg,视力≥0.5。结论: 白内障超声乳化联合人工晶状体植入术能够安全、有效地治疗晶状体溶解性青光眼。

·AIM： To evaluate the therapeutic effect of phacoemulsification and intraocular lens implantation on phacolytic glaucoma.· METHODS： A survey of the operative complications, visual activity and intraocular pressure was taken, after the cases received the operation of phacoemulsification and intraocular lens implantation for phacolytic glaucoma. ·RESULTS： The complications of the surgery were slight and easy to control. The intraocular pressure of 17 cases was between 41.7-62.4mmHg before the surgery, and it was 10.7-18.2mmHg after the surgery. Furthermore, the visual activity was light perception （LP） in pre-operation while it was ≥0.5 postoperatively. · CONCLUSION ： Phacoemulsification and intraocular lens implantation is a safe and effect way for phacolytic glaucoma.